Dynamic Advisor Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
2,984
-565
-16% -$250K 0.04% 396
2026
Q1
$1.58M Sell
3,549
-119
-3% -$55.5K 0.05% 363
2025
Q4
$1.66M Sell
3,668
-110
-3% -$47.4K 0.05% 338
2025
Q3
$1.48M Buy
3,778
+839
+29% +$351K 0.04% 385
2025
Q2
$1.31M Buy
2,939
+148
+5% +$68.2K 0.04% 386
2025
Q1
$1.35M Buy
+2,791
New +$1.3M 0.04% 356
2024
Q4
Sell
-3,211
Closed -$1.49M 901
2024
Q3
$1.49M Sell
3,211
-2,972
-48% -$1.43M 0.04% 359
2024
Q2
$2.9M Buy
6,183
+477
+8% +$207K 0.09% 243
2024
Q1
$2.39M Buy
5,706
+3,363
+144% +$1.42M 0.08% 274
2023
Q4
$976K Buy
2,343
+95
+4% +$35.1K 0.04% 420
2023
Q3
$782K Buy
2,248
+441
+24% +$154K 0.04% 409
2023
Q2
$636K Buy
1,807
+583
+48% +$196K 0.03% 440
2023
Q1
$386K Buy
1,224
+295
+32% +$88.5K 0.02% 532
2022
Q4
$268K Buy
+929
New +$283K 0.02% 583

Other funds holding VRTX

Dynamic Advisor Solutions's VRTX Position: Q2 2026 in Review

Dynamic Advisor Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q2 2026, selling an estimated $250K and leaving 2,984 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #396.

Dynamic Advisor Solutions first reported a position in VRTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.9M in Q2 2024. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Dynamic Advisor Solutions held 2,984 shares of Vertex Pharmaceuticals worth $1.48M as of Q2 2026.
  • Dynamic Advisor Solutions sold 565 Vertex Pharmaceuticals shares in Q2 2026, an estimated $250K.
  • Vertex Pharmaceuticals made up 0.04% of Dynamic Advisor Solutions's portfolio in Q2 2026, its #396 holding.
  • Dynamic Advisor Solutions first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Dynamic Advisor Solutions's Vertex Pharmaceuticals position peaked at $2.9M in Q2 2024.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Dynamic Advisor Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.